4head User Evaluation.

Dermal Laboratories Limited0 个研究点目标入组 22 人开始时间: 2005年9月12日最近更新: 2019年11月25日

适应症

试验速览

暂无简介。

•Male or female subjects will be eligible for inclusion in the study provided they have a declared history of experiencing tension-type headaches at least twice weekly.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•i) Subjects less than 18 years old.
•ii) Subjects with a history of known or suspected intolerance to menthol or levomenthol.
•iii) Subjects receiving any unlicensed drug within the last 30 days or scheduled to receive an investigative drug other than the study medication during the period of the study.
•iii) Subjects who have any other condition, whether being treated or not, which, in the opinion of the Investigator, may adversely influence their participation in the trial.
•iv) Female subjects, if they are possibly pregnant or breast-feeding and / or not using a medically approved form of contraception.
•v) Subjects considered unable or unlikely to be able to complete the questionnaire/diary or to attend the necessary final visit.
•vi) Subjects concurrently participating in any other test involving an Investigational Product.
•vii) Subjects who have participated in a research study in the previous 4 weeks involving the same skin site.
•viii) Subjects who have any skin pathology, scars, tattoos, or birthmarks at the test site likely to interfere with the study.
•ix) Subjects who are an employee of Sequani Clinical or Dermal Laboratories, or an immediate family member (partner, offspring, parents, siblings or sibling’s offspring) of an employee.

发起方